TO CONTROL OR PREVENT A POSTOPERATIVE INCREASE IN INTRA-OCULAR PRESSURE IN PATIENTS UNDERGOING ANTERIOR SEGMENT LASER SURGERY, A 1% SOLUTION IS INSTILLED INTO THE EYE ONE HOUR BEFORE SURGERY AND AGAIN IMMEDIATELY UPON COMPLETION OF SURGERY.
FOR SHORT-TERM ADJUNCTIVE THERAPY IN PATIENTS WITH RAISED INTRA-OCULAR PRESSURE NOT CONTROLLED BY CONVENTIONAL THERAPY, A 0.5% SOLUTION MAY BE INSTILLED THREE TIMES DAILY.
THERE IS A LOSS OF EFFECT OVER TIME (TACHYPHYLAXIS) WITH APRACLONIDINE AND THE BENEFIT IN MOST PATIENTS LASTS FOR LESS THAN A MONTH.